论文部分内容阅读
建国三十多年以来,我国尚没有一个独创的新药真正打入国际市场。其原因当然是各种多样的,但我们认为,我国对新药生物活性研究的基础比较薄弱是重要原因之一。那末,又如何才能加强新药的生物活性研究呢?同样,在这方面涉及的因素也是很多的。有些专家认为:加强投资,建立新药研究基地就是这众多因素中的主要方面。现发表这些专家对上述问题的看法,以供读者及有关人员参考。
Since the founding of the People’s Republic of China for more than 30 years, there has not been a unique new drug that has really entered the international market in our country. The reason is of course varied, but we think that one of the important reasons is the weak foundation of our study on the biological activity of new drugs. Then how can we enhance the biological activity of new drugs? Similarly, there are many factors involved in this aspect. Some experts believe that strengthening investment and establishing new drug research bases are the major aspects of these many factors. The opinions of these experts on these issues are published for reference of readers and relevant personnel.